In a commentary in the journal Academic Medicine, titled “We Burn Out, We Break, We Die: Medical Schools Must Change Their Culture to Preserve Medical Student Mental Health,” fourth-year Larner medical student Christopher Veal reveals his personal experiences as a Black man dealing with depression and suicide ideation and calls on the medical education community to change its culture to support the mental health of its learners.

New findings, reported in Nature Communications and published by UVM researchers, describe the discovery of a unique dependence of cancer cells on a particular protein, which could lead to desperately-needed treatment for hard-to-treat cancers.

Amid the biomedical science world’s race to develop and distribute vaccines and treatments for COVID-19, a hard-working team made up of a Larner College of Medicine scientist and partners at Lebanon, N.H.-based Celdara Medical are busy building a potentially game-changing therapy to fight RNA viruses like SARS-CoV-2.

In developing therapies for hard-to-treat breast and ovarian cancers in patients with BRCA gene mutations, scientists aim to identify ways to keep cancer cells from using DNA break repair pathways. New findings from researchers including UVM Professor Sylvie Doublie demonstrate a previously-unknown capability for a key enzyme in this repair function that shows promise as a new avenue for treatment development.